Scott Richard

TitleAssoc Professor
InstitutionThomas Jefferson University
DepartmentObstetrics-Gynecology
Address833 Chestnut Street
Philadelphia PA 19107
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Cao CD, Rico-Castillo J, De Cotiis D, Richard SD, Rosenblum NG, Chan JSY. Digital Quantification of Ki-67 and PHH3 in the Classification of Uterine Smooth Muscle Tumors. Int J Gynecol Pathol. 2020 Dec 14. PMID: 33323861.
      Citations:    
    2. Yegya-Raman N, Cao CD, Hathout L, Girda E, Richard SD, Rosenblum NG, Taunk NK, Jabbour SK. Stereotactic body radiation therapy for oligometastatic gynecologic malignancies: A systematic review. Gynecol Oncol. 2020 Nov; 159(2):573-580. PMID: 32917412.
      Citations:    
    3. Thadi A, Gleeson EM, Khalili M, Shaikh MF, Goldstein E, Morano WF, Daniels LM, Grandhi N, Glatthorn H, Richard SD, Campbell PM, Sarafraz-Yazdi E, Pincus MR, Bowne WB. Anti-Cancer Tumor Cell Necrosis of Epithelial Ovarian Cancer Cell Lines Depends on High Expression of HDM-2 Protein in Their Membranes. Ann Clin Lab Sci. 2020 Sep; 50(5):611-624. PMID: 33067207.
      Citations:    
    4. Gaulin NB, Lesnock JL, Tian C, Osei-Bonsu K, Jacobs A, Richard SD, Krivak TC, Miller EM, Shriver CD, Casablanca Y, Maxwell GL, Darcy KM. Survival disparities in vulvar cancer patients in Commission on Cancer®-accredited facilities. Gynecol Oncol. 2019 Dec 05. PMID: 31954540.
      Citations:    
    5. Delaney LJ, Machado P, Torkzaban M, Lyshchik A, Wessner CE, Kim C, Rosenblum N, Richard S, Wallace K, Forsberg F. Characterization of Adnexal Masses Using Contrast-Enhanced Subharmonic Imaging: A Pilot Study. J Ultrasound Med. 2019 Nov 26. PMID: 31769529.
      Citations:    
    6. Quist-Nelson J, Crank A, Oliver E, Kim C, Richard S, George B, Chan J, Quist A, Berghella V, Roman A. The compliance with a patient safety bundle for management of placenta accreta spectrum. J Matern Fetal Neonatal Med. 2019 Sep 25; 1-291. PMID: 31550959.
      Citations:    
    7. Thadi A, Khalili M, Morano WF, Richard SD, Katz SC, Bowne WB. Erratum: Thadi A.; et al. Early Investigations and Recent Advances in Intraperitoneal Immunotherapy for Peritoneal Metastasis. Vaccines 2018, 6, 54. Vaccines (Basel). 2019 Jan 31; 7(1). PMID: 30708956.
      Citations:    
    8. Lee TY, Martinez-Outschoorn UE, Schilder RJ, Kim CH, Richard SD, Rosenblum NG, Johnson JM. Metformin as a Therapeutic Target in Endometrial Cancers. Front Oncol. 2018; 8:341. PMID: 30211120.
      Citations:    
    9. Thadi A, Khalili M, Morano WF, Richard SD, Katz SC, Bowne WB. Early Investigations and Recent Advances in Intraperitoneal Immunotherapy for Peritoneal Metastasis. Vaccines (Basel). 2018 Aug 10; 6(3). PMID: 30103457.
      Citations:    
    10. Kohut A, Orfanelli T, Poggio JL, Gibbon D, Buckley De Meritens A, Richard S. Morbidity and Mortality Risk Assessment in Gynecologic Oncology Surgery Using the American College of Surgeons National Surgical Quality Improvement Program Database. Int J Gynecol Cancer. 2018 May; 28(4):840-847. PMID: 29664848.
      Citations:    
    11. Horowitz NS, Larry Maxwell G, Miller A, Hamilton CA, Rungruang B, Rodriguez N, Richard SD, Krivak TC, Fowler JM, Mutch DG, Van Le L, Lee RB, Argenta P, Bender D, Tewari KS, Gershenson D, Java JJ, Bookman MA. Predictive modeling for determination of microscopic residual disease at primary cytoreduction: An NRG Oncology/Gynecologic Oncology Group 182 Study. Gynecol Oncol. 2018 Jan; 148(1):49-55. PMID: 29174555.
      Citations:    
    12. Varadarajan I, Basu A, Besmer S, Poli J, Richard S, Styler M. Solitary Skeletal Muscle Metastasis as First Site of Recurrence of Cervical Cancer: A Case Report. Case Rep Oncol. 2017 May-Aug; 10(2):694-698. PMID: 28878652.
      Citations:    
    13. Rungruang BJ, Miller A, Krivak TC, Horowitz NS, Rodriguez N, Hamilton CA, Backes FJ, Carson LF, Friedlander M, Mutch DG, Goodheart MJ, Tewari KS, Wenham RM, Bookman MA, Maxwell GL, Richard SD. What is the role of retroperitoneal exploration in optimally debulked stage IIIC epithelial ovarian cancer? An NRG Oncology/Gynecologic Oncology Group ancillary data study. Cancer. 2017 May 15; 123(6):985-993. PMID: 27864921.
      Citations:    
    14. Danis RB, Della Badia CR, Richard SD. Postpartum Permanent Sterilization: Could Bilateral Salpingectomy Replace Bilateral Tubal Ligation? J Minim Invasive Gynecol. 2016 Sep-Oct; 23(6):928-32. PMID: 27234430.
      Citations:    
    15. Boisen MM, Lesnock JL, Richard SD, Beriwal S, Kelley JL, Zorn KK, Edwards RP. Second-line Intraperitoneal Platinum-based Therapy Leads to an Increase in Second-line Progression-free Survival for Epithelial Ovarian Cancer. Int J Gynecol Cancer. 2016 May; 26(4):626-31. PMID: 27051048.
      Citations:    
    16. Boisen MM, Richard SD, Holtzman MP, Edwards RP, Kelley JL, Choudry MH, Bartlett D, Huang M. Hyperthermic intraperitoneal chemotherapy for epithelial ovarian cancers: is there a role? J Gastrointest Oncol. 2016 Feb; 7(1):10-7. PMID: 26941980; PMCID: PMC4754311.
      Citations:    
    17. Horowitz N, Miller A, Rungruang B, Richard S, Rodriguez N, Bookman MA, Hamilton C, Krivak T, Maxwell GL. Reply to G.D. Aletti et al. J Clin Oncol. 2015 Oct 20; 33(30):3521-2. PMID: 26304879.
      Citations:    
    18. Richard S, Wells A, Connor J, Price F. Use of ChemoFx® for Identification of Effective Treatments in Epithelial Ovarian Cancer. PLoS Curr. 2015 Jul 13; 7. PMID: 26213638; PMCID: PMC4506277.
      Citations:    
    19. Horowitz NS, Miller A, Rungruang B, Richard SD, Rodriguez N, Bookman MA, Hamilton CA, Krivak TC, Maxwell GL. Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182. J Clin Oncol. 2015 Mar 10; 33(8):937-43. PMID: 25667285; PMCID: PMC4348639.
      Citations:    
    20. Pereira N, Buchanan TR, Wishall KM, Kim SH, Grias I, Richard SD, Della Badia CR. Electric morcellation-related reoperations after laparoscopic myomectomy and nonmyomectomy procedures. J Minim Invasive Gynecol. 2015 Feb; 22(2):163-76. PMID: 25218993.
      Citations:    
    21. Laskey RA, Richard SD, Smith AL, Lin JF, Beck TL, Lesnock JL, Kelley JL, Olawaiye AB, Sukumvanich P, Krivak TC. Retreatment with bevacizumab in patients with gynecologic malignancy is associated with clinical response and does not increase morbidity. Onco Targets Ther. 2014; 7:469-76. PMID: 24711703; PMCID: PMC3968081.
      Citations:    
    22. Krivak TC, Lele S, Richard S, Secord AA, Leath CA, Brower SL, Tian C, Moore RG. A chemoresponse assay for prediction of platinum resistance in primary ovarian cancer. Am J Obstet Gynecol. 2014 Jul; 211(1):68.e1-8. PMID: 24530815.
      Citations:    
    23. Lin JF, Berger JL, Krivak TC, Beriwal S, Chan JK, Sukumvanich P, Monk BJ, Richard SD. Impact of facility volume on therapy and survival for locally advanced cervical cancer. Gynecol Oncol. 2014 Feb; 132(2):416-22. PMID: 24333361.
      Citations:    
    24. Pereira N, Yao R, Guilfoil DS, Richard SD, Plante LA. Placenta membranacea with placenta accreta: radiologic diagnosis and clinical implications. Prenat Diagn. 2013 Dec; 33(13):1293-6. PMID: 24018907.
      Citations:    
    25. Rodriguez N, Miller A, Richard SD, Rungruang B, Hamilton CA, Bookman MA, Maxwell GL, Horowitz NS, Krivak TC. Upper abdominal procedures in advanced stage ovarian or primary peritoneal carcinoma patients with minimal or no gross residual disease: an analysis of Gynecologic Oncology Group (GOG) 182. Gynecol Oncol. 2013 Sep; 130(3):487-92. PMID: 23791702.
      Citations:    
    26. Beriwal S, Kannan N, Sukumvanich P, Richard SD, Kelley JL, Edwards RP, Olawaiye A, Krivak TC. Complete metabolic response after definitive radiation therapy for cervical cancer: patterns and factors predicting for recurrence. Gynecol Oncol. 2012 Nov; 127(2):303-6. PMID: 22902917.
      Citations:    
    27. Smith AL, Krivak TC, Scott EM, Rauh-Hain JA, Sukumvanich P, Olawaiye AB, Richard SD. Dual-console robotic surgery compared to laparoscopic surgery with respect to surgical outcomes in a gynecologic oncology fellowship program. Gynecol Oncol. 2012 Sep; 126(3):432-6. PMID: 22613352.
      Citations:    
    28. Kannan N, Beriwal S, Kim H, Houser C, Mogus R, Sukumvanich P, Olawaiye AB, Richard S, Kelley JL, Edwards RP, Krivak TC. High-dose-rate interstitial computed tomography-based brachytherapy for the treatment of cervical cancer: early results. Brachytherapy. 2012 Sep-Oct; 11(5):408-12. PMID: 22513106.
      Citations:    
    29. Smith AL, Scott EM, Krivak TC, Olawaiye AB, Chu T, Richard SD. Dual-console robotic surgery: a new teaching paradigm. J Robot Surg. 2013 Jun; 7(2):113-8. PMID: 23704858; PMCID: PMC3657076.
      Citations:    
    30. Rungruang B, Courtney-Brooks M, Beriwal S, Zorn KK, Richard SD, Olawaiye AB, Krivak TC, Sukumvanich P. Surgery versus radiation therapy for stage IB2 cervical carcinoma: a population-based analysis. Int J Gynecol Cancer. 2012 Mar; 22(3):484-9. PMID: 22249576.
      Citations:    
    31. Skaznik-Wikiel ME, Lesnock JL, McBee WC, Beriwal S, Zorn KK, Richard SD, Krivak TC, Edwards RP. Intraperitoneal chemotherapy for recurrent epithelial ovarian cancer is feasible with high completion rates, low complications, and acceptable patient outcomes. Int J Gynecol Cancer. 2012 Feb; 22(2):232-7. PMID: 22080886.
      Citations:    
    32. Rungruang B, Miller A, Richard SD, Hamilton CA, Rodriguez N, Bookman MA, Maxwell GL, Krivak TC, Horowitz NS. Should stage IIIC ovarian cancer be further stratified by intraperitoneal vs. retroperitoneal only disease?: a Gynecologic Oncology Group study. Gynecol Oncol. 2012 Jan; 124(1):53-8. PMID: 22032836.
      Citations:    
    33. Skaznik-Wikiel ME, Sukumvanich P, Beriwal S, Zorn KK, Kelley JL, Richard SD, Krivak TC. Possible use of CA-125 level normalization after the third chemotherapy cycle in deciding on chemotherapy regimen in patients with epithelial ovarian cancer: brief report. Int J Gynecol Cancer. 2011 Aug; 21(6):1013-7. PMID: 21792011.
      Citations:    
    34. Beriwal S, Rwigema JC, Higgins E, Kim H, Houser C, Sukumvanich P, Olawaiye A, Richard S, Kelley JL, Edwards RP, Krivak TC. Three-dimensional image-based high-dose-rate interstitial brachytherapy for vaginal cancer. Brachytherapy. 2012 May-Jun; 11(3):176-80. PMID: 21665553.
      Citations:    
    35. Huh WK, Cibull M, Gallion HH, Gan CM, Richard S, Cohn DE. Consistency of in vitro chemoresponse assay results and population clinical response rates among women with endometrial carcinoma. Int J Gynecol Cancer. 2011 Apr; 21(3):494-9. PMID: 21430456.
      Citations:    
    36. Taylor SE, McBee WC, Richard SD, Edwards RP. Radical hysterectomy for early stage cervical cancer: laparoscopy versus laparotomy. JSLS. 2011 Apr-Jun; 15(2):213-7. PMID: 21902978; PMCID: PMC3148874.
      Citations:    
    37. Richard SD, Bencherif B, Edwards RP, Elishaev E, Krivak TC, Mountz JM, DeLoia JA. Noninvasive assessment of cell proliferation in ovarian cancer using [18F] 3'deoxy-3-fluorothymidine positron emission tomography/computed tomography imaging. Nucl Med Biol. 2011 May; 38(4):485-91. PMID: 21531285.
      Citations:    
    38. Teng PN, Rungruang BJ, Hood BL, Sun M, Flint MS, Bateman NW, Dhir R, Bhargava R, Richard SD, Edwards RP, Conrads TP. Assessment of buffer systems for harvesting proteins from tissue interstitial fluid for proteomic analysis. J Proteome Res. 2010 Aug 06; 9(8):4161-9. PMID: 20518575.
      Citations:    
    39. Richard SD, Sukumvanich P, Lesnock JL, McBee WC, Beriwal S, Edwards RP, Zorn KK, Krivak TC. Intraperitoneal catheter leads to prolongation of the time to normalization of serum CA125 levels. Int J Gynecol Cancer. 2010 Aug; 20(6):932-5. PMID: 20683398.
      Citations:    
    40. Smaldone GM, Richard SD, Edwards RP. Pregnancy outcomes after conservative surgical management of ovarian neoplasms treated at a single institution. Int J Gynecol Cancer. 2010 Aug; 20(6):926-31. PMID: 20683397.
      Citations:    
    41. Courtney-Brooks M, Sukumvanich P, Beriwal S, Zorn KK, Richard SD, Krivak TC. Does the number of nodes removed impact survival in vulvar cancer patients with node-negative disease? Gynecol Oncol. 2010 May; 117(2):308-11. PMID: 20153883.
      Citations:    
    42. Wegner RE, Beriwal S, Heron DE, Richard SD, Kelly JL, Edwards RP, Sukumvanich P, Zorn KK, Krivak TC. Definitive radiation therapy for endometrial cancer in medically inoperable elderly patients. Brachytherapy. 2010 Jul-Sep; 9(3):260-5. PMID: 20122872.
      Citations:    
    43. Helm CW, Richard SD, Pan J, Bartlett D, Goodman MD, Hoefer R, Lentz SS, Levine EA, Loggie BW, Metzinger DS, Miller B, Parker L, Spellman JE, Sugarbaker PH, Edwards RP, Rai SN. Hyperthermic intraperitoneal chemotherapy in ovarian cancer: first report of the HYPER-O registry. Int J Gynecol Cancer. 2010 Jan; 20(1):61-9. PMID: 20130504.
      Citations:    
    44. Lesnock JL, Richard SD, Zorn KK, Krivak TC, Beriwal S, Sukumvanich P, McBee WC, Kelley JL, Edwards RP. Completion of intraperitoneal chemotherapy in advanced ovarian cancer and catheter-related complications. Gynecol Oncol. 2010 Mar; 116(3):345-50. PMID: 19959211.
      Citations:    
    45. Richard SD, Krivak TC, Castleberry A, Beriwal S, Kelley JL, Edwards RP, Sukumvanich P. Survival for stage IB cervical cancer with positive lymph node involvement: a comparison of completed vs. abandoned radical hysterectomy. Gynecol Oncol. 2008 Apr; 109(1):43-8. PMID: 18234297.
      Citations:    
    46. Gusani NJ, Cho SW, Colovos C, Seo S, Franko J, Richard SD, Edwards RP, Brown CK, Holtzman MP, Zeh HJ, Bartlett DL. Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center. Ann Surg Oncol. 2008 Mar; 15(3):754-63. PMID: 18080166.
      Citations:    
    47. Smaldone GM, Richard SD, Krivak TC, Kelley JL, Edwards RP. Pregnancy after tumor debulking and intraperitoneal cisplatin for appendiceal carcinoid tumor. Obstet Gynecol. 2007 Aug; 110(2 Pt 2):477-9. PMID: 17666634.
      Citations:    
    48. Abu-Rustum NR, Richard S, Wilton A, Lev G, Sonoda Y, Hensley ML, Gemignani M, Barakat RR, Chi DS. Transfusion utilization during adnexal or peritoneal cancer surgery: effects on symptomatic venous thromboembolism and survival. Gynecol Oncol. 2005 Nov; 99(2):320-6. PMID: 16061278.
      Citations:    
    Richard's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (176)
    Explore
    _
    Co-Authors (10)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _